/

COSM

Cosmos Health Inc.Pre-market

0.3829+0.03 +9.53%USD

NasdaqCM · as of Oct 13, 16:00 ET · 15m delayPre-market 0.3700 −3.37%

Open

0.3600

Prev close

0.3496

Day range

0.34960.4000

52-week range

0.16201.26

Volume

4.11M1.14×

Mkt cap

38.53M

P/E ttm

—

Fwd P/E

5.47

EPS ttm

-0.6500

Div yield

0.00%

Earnings

—

From 52w high

−69.49%

Price Chart

Yahoo Finance · delayed

COSMOct 13, 2026O 0.3600H 0.4000L 0.3470C 0.3830+0.0330 (+9.43%)Vol 4.12M

SMA 500.2793
SMA 2000.3253

1Y change −62.45% since Oct 13, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

COSM Cosmos Health Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: +19.69%
1 month: +50.79%
3 months: +24.76%
6 months: +14.67%
Year to date: −23.09%
1 year: −62.45%

Valuation & ownership

Market cap: 38.53M
Enterprise value: 52.67M
P/E (ttm): —
Forward P/E: 5.47
PEG ratio: —
Price / book: 1.50
Price / sales (ttm): 0.52
EV / EBITDA: -3.14
EPS (ttm): -0.6500
EPS (forward): 0.0700
Beta (5y monthly): 4.21
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 100.63M
Float: 78.78M
Short % of float: 2.99%
Short ratio (days): 0.63
Held by insiders: 21.68%
Held by institutions: 3.68%
Avg volume (3m): 3.61M
50-day average: 0.2764
200-day average: 0.3260
52-week change: −62.45%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): 60.6
vs 50-day SMA: +37.12%
vs 200-day SMA: +17.75%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▼ below
ATR (14) % of price: 10.76%
Realised vol (20d, ann.): 117.1%
From 52-week high: −69.48%
From 52-week low: +136.42%

ANR

Analyst Consensus

1 analysts

Consensus

Strong buy

0.00 on a 1 (strong buy) – 5 (sell) scale

Mean target

4.50

+1,075.24% implied

Low 4.50Median 4.50High 4.50

Recommendation trend

Now0 / 0 / 0
1m ago0 / 0 / 0
2m ago

DES

About Cosmos Health Inc.

Yahoo Finance profile

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.

Sector: Healthcare
Industry: Medical Distribution
Employees: 163
Headquarters: Thessaloniki, Greece
Website: cosmoshealthinc.com
Officers: Mr. Grigorios Siokas Chairman & CEO

SEAS

Seasonality · COSM

2010–2026 · monthly returns

Strongest month Nov +54.56%Weakest month Apr −7.81%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-3.6	-18.1	-19.3	15.8	-32.7	-25.1	16.8	12.5	77.0	-11.0			−23.1%
2025	5.8	-22.6	-20.4	-2.8	4.7	-5.4	120.2	-14.6	40.5	-27.0	-20.7	-22.4	−25.6%
2024	-24.5	-27.2	-8.4	-3.5	0.7	50.7	16.3	-3.7	-24.8	-13.2	5.1	-16.3	−52.6%
2023	42.3	-48.2	5.4	-4.8	1.5	-12.6	-47.5	-23.6	30.8	-34.4	1.0	35.6	−69.1%
2022	-3.6	5.4	-37.6	-50.9	1.9	-65.4	-4.1	0.8	-42.7	-58.5	600.0	666.4	+35.3%
2021	-6.5	0.2	20.3	3.5	-16.0	6.0	-24.5	7.5	8.1	-11.8	-16.1	-2.0	−33.9%
2020	-22.3	46.2	-20.4	3.0	16.6	21.3	-17.9	67.2	-11.6	13.6	36.2	-6.4	+131.8%
2019	-40.0	52.1	-4.1	-23.1	28.3	-7.2	12.8	-21.1	15.8	-11.5	-10.3	-16.0	−45.0%
2018	11.8	-4.8	-17.1	-38.8	41.8	-17.8	7.6	2.9	-36.6	-11.1	79.5	-44.3	−60.8%
2017	6.1	-3.4	-0.6	-13.8	-5.6	-2.9	-15.2	-1.8	-1.8	8.3	42.7	22.2	+24.4%
2016	-36.3	0.0	49.0	-38.2	24.5	2.6	16.7	-7.1	-7.7	6.7	-18.8	57.7	+2.5%
2015	-8.0	-6.2	-1.3	-14.7	4.7	19.4	17.5	-17.0	-30.8	48.1	8.1	-7.5	−9.1%
2014	-2.5	-3.4	4.3	0.0	-7.5	-0.9	-2.7	-7.0	9.5	-13.8	3.2	-9.3	−27.9%
2013	0.0	38.9	56.0	41.0	-27.3	12.5	0.0	33.3	5.0	33.3	52.4	-4.7	+577.8%
2012	-21.6	0.0	0.0	-7.5	-73.0	100.0	95.0	0.0	0.0	-51.3	110.5	-55.0	−64.7%
2011	-1.0	-25.0	-20.0	33.3	12.5	-16.7	0.0	60.0	-62.5	66.7	0.0	-32.0	−49.5%
2010								-44.0	0.0	28.6	0.0	12.2	−19.2%

INSD

Insider Activity · COSM

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

9.17M shares

Sells, 6 months

2.77M shares

Net shares

+6.40M

Net change in insider shares

+41.50%

Date	Insider	Transaction	Shares	Value
Jul 29, 2026	Siokas GrigoriosChief Executive Officer	Purchase at price 0.20 per share.	349.8K	$70.00K
Jul 28, 2026	Terzis GeorgiosChief Financial Officer	Stock Award(Grant) at price 0.18 per share.	328.4K	$60.00K
Jul 28, 2026	Siokas GrigoriosChief Executive Officer	Purchase at price 0.18 per share.	766.3K	$140.00K
Jun 15, 2026	Terzis GeorgiosChief Financial Officer	Purchase at price 0.25 per share.	168.1K	$42.00K
Jun 10, 2026	Siokas GrigoriosChief Executive Officer	Purchase at price 0.21 per share.	218.4K	$45.00K
Jun 9, 2026	Siokas GrigoriosChief Executive Officer	Purchase at price 0.23 per share.	701.4K	$160.00K
May 18, 2026	Hoidas John JamesDirector	Conversion of Exercise of derivative security at price 0.28 per share.	20K	$5.65K
May 18, 2026	Terzis GeorgiosChief Financial Officer	Conversion of Exercise of derivative security at price 0.28 per share.	850K	$240.13K
May 18, 2026	Bhutawala SuhelDirector	Conversion of Exercise of derivative security at price 0.28 per share.	20K	$5.65K
May 18, 2026	Demetriades Demetrios GOfficer and Director	Conversion of Exercise of derivative security at price 0.28 per share.	20K	$5.66K
May 18, 2026	Karkantzos Theodoros C.Director	Conversion of Exercise of derivative security at price 0.28 per share.	2K	$565
May 18, 2026	Siokas GrigoriosChief Executive Officer	Conversion of Exercise of derivative security at price 0.28 per share.	2.35M	$663.88K
May 18, 2026	Aslidis AnastasiosDirector	Conversion of Exercise of derivative security at price 0.28 per share.	40K	$11.30K
May 18, 2026	Bhutawala SuhelDirector	Stock Award(Grant) at price 0.28 per share.	20K	$5.66K
May 18, 2026	Demetriades Demetrios GOfficer and Director	Stock Award(Grant) at price 0.28 per share.	20K	$5.66K
May 18, 2026	Karkantzos Theodoros C.Director	Stock Award(Grant) at price 0.28 per share.	20K	$5.66K
May 18, 2026	Siokas GrigoriosChief Executive Officer	Stock Award(Grant) at price 0.28 per share.	2.35M	$665.05K
May 18, 2026	Aslidis AnastasiosDirector	Stock Award(Grant) at price 0.28 per share.	40K	$11.32K
May 18, 2026	Hoidas John JamesDirector	Stock Award(Grant) at price 0.28 per share.	20K	$5.66K
May 18, 2026	Terzis GeorgiosChief Financial Officer	Stock Award(Grant) at price 0.28 per share.	850K	$240.55K

COSM

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

COSM

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Cosmos Health Inc.

Seasonality · COSM

Insider Activity · COSM

Congress Trades · COSM

Investors Holding COSM

Investors Holding COSM

Congress Trades · COSM

Insider Activity · COSM

Seasonality · COSM

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Cosmos Health Inc.

Financial Snapshot

Earnings & Dividends

News